Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01745328|
Recruitment Status : Unknown
Verified December 2012 by Beijing Institute of Disease Control and Prevention.
Recruitment status was: Recruiting
First Posted : December 10, 2012
Last Update Posted : December 10, 2012
|Condition or disease||Intervention/treatment||Phase|
|Recurrent Urinary Tract Infection||Drug: LVX-AMX Drug: TCM||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Study on Treatment of Recurrent Urinary Tract Infection by Traditional Chinese Medicine|
|Study Start Date :||January 2009|
|Estimated Primary Completion Date :||March 2013|
|Estimated Study Completion Date :||July 2013|
Active Comparator: LVX-AMX
subject is treated with LAV-AMX, then followed by placebo.
Subjects were treated with Levofloxacin, 200mg bid, Amoxicillin, 500mg tid for 1 week, followed by 3 week of placebo.
Other Name: Levofloxacin, 200mg bid, Amoxicillin, 500mg tid
treatment with placebo from 2 to 4 weeks.
Other Name: placebo from 2 to 4 weeks.
Active Comparator: TCM treatment
subject is treated with TCM
Subject is treated with TCM for 4 weeks.
Other Name: TCM formula consisted of 10 herbals
- Recovery of recurrent urinary tract infection [ Time Frame: 4 weeks after study drug start ]Patients are checked at 4 weeks at the end of the treatment to confirm recovery of RUTI.
- Urinary albumin [ Time Frame: 4 weeks after drug start ]Urinary albumin is checked in patient urine.
- WBC conversion [ Time Frame: 4 weeks after drug start ]Check the WBC count in patient urine.
- Urination frequency [ Time Frame: 4 weeks after drug start ]Checked for urination frequency at 4 weeks after drug start.
- Recurrence [ Time Frame: 6 months after drug start ]Patients are checked for recurrence rate at 6 months after drug start by telephone interview.
- urgency [ Time Frame: 4 weeks after drug start ]Check urgency 4 weeks after drug start
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01745328
|Contact: Shiwei Liu, Dremail@example.com|
|Beijing, Beijing, China, 100020|
|Contact: Shiwei Liu, Dr 86-10-84739029 firstname.lastname@example.org|
|Principal Investigator: Shiwei Liu, Dr|
|Principal Investigator:||Zeliang Chen, Dr||Insititute of Disease Control and Prevention|